Propionic Acid Shapes the Multiple Sclerosis Disease Course by an Immunomodulatory MechanismAlexander Duscha, Aiden Haghikia, Gabriele I. Stangl et al.|Cell|2020Cited by 627
TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosisAdam Gregory, Lars Fugger, Calliope A. Dendrou et al.|Nature|2012Cited by 382